SEC Filings | Talaris Therapeutics, Inc.

Filing date	Description	Form	Filing Group	View
Sep 13, 2023	CORRESP	CORRESP	Other	0001193125-23-234397.pdf 0001193125-23-234397.rtf 0001193125-23-234397.xls View HTML
Sep 11, 2023	Pre-effective amendment to an S-4 filing	S-4/A	Registration Statements	0001193125-23-232536.pdf 0001193125-23-232536.rtf 0001193125-23-232536.xls View HTML
Sep 11, 2023	CORRESP	CORRESP	Other	0001193125-23-232540.pdf 0001193125-23-232540.rtf 0001193125-23-232540.xls View HTML
Sep 06, 2023	UPLOAD	UPLOAD	Other	0000000000-23-009850.pdf 0000000000-23-009850.rtf View HTML
Aug 28, 2023	Filing of certain prospectuses and communications in connection with business combination transactions	425	Other	0001193125-23-222073.pdf 0001193125-23-222073.rtf View HTML
Aug 25, 2023	Pre-effective amendment to an S-4 filing	S-4/A	Registration Statements	0001193125-23-221553.pdf 0001193125-23-221553.rtf 0001193125-23-221553.xls View HTML
Aug 25, 2023	CORRESP	CORRESP	Other	0001193125-23-221557.pdf 0001193125-23-221557.rtf View HTML
Aug 16, 2023	UPLOAD	UPLOAD	Other	0000000000-23-008942.pdf 0000000000-23-008942.rtf View HTML
Aug 16, 2023	SEC Staff Letter: 14A-8	SEC STAFF LETTER		9999999997-23-003886.pdf View HTML
Aug 14, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	0000950170-23-042065.pdf 0000950170-23-042065.rtf 0000950170-23-042065.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.